SPTY2D1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.69864122767649E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.78589961999876E-10 |
Normal-vs-Stage2 |
4.09180000000564E-05 |
Normal-vs-Stage3 |
7.04991620636974E-14 |
Normal-vs-Stage4 |
1.86972659577123E-12 |
Stage1-vs-Stage2 |
9.312200E-01 |
Stage1-vs-Stage3 |
8.802500E-04 |
Stage1-vs-Stage4 |
1.476350E-03 |
Stage2-vs-Stage3 |
4.576100E-02 |
Stage2-vs-Stage4 |
4.089800E-02 |
Stage3-vs-Stage4 |
8.413200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.91699997490014E-12 |
Normal-vs-AfricanAmerican |
6.23150420153706E-11 |
Normal-vs-Asian |
1.603700E-02 |
Caucasian-vs-AfricanAmerican |
1.257410E-01 |
Caucasian-vs-Asian |
7.669200E-01 |
AfricanAmerican-vs-Asian |
3.550600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.00759417370955E-13 |
Normal-vs-Female |
1.51039958318222E-10 |
Male-vs-Female |
2.193600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.49979999974903E-07 |
Normal-vs-Age(41-60Yrs) |
3.82920029018408E-10 |
Normal-vs-Age(61-80Yrs) |
2.13729034470589E-12 |
Normal-vs-Age(81-100Yrs) |
4.93629999986922E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.769970E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.819400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.709200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.376400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.179400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.353200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.132000E-02 |
Normal-vs-Grade 2 |
4.82980000438005E-08 |
Normal-vs-Grade 3 |
1.63768998362457E-12 |
Normal-vs-Grade 4 |
1.626032641866E-12 |
Grade 1-vs-Grade 2 |
3.761200E-01 |
Grade 1-vs-Grade 3 |
3.953700E-02 |
Grade 1-vs-Grade 4 |
2.982800E-03 |
Grade 2-vs-Grade 3 |
2.137900E-03 |
Grade 2-vs-Grade 4 |
4.11070000000402E-05 |
Grade 3-vs-Grade 4 |
4.490100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.75949999967362E-07 |
Normal-vs-ccB subtype |
6.36124486419476E-12 |
ccA subtype-vs-ccB subtype |
1.476600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.20390405714488E-11 |
Normal-vs-N1 |
2.06589999999229E-05 |
N0-vs-N1 |
3.535800E-01 |
|
|